Avenue Biosciences secures $5.7M in Seed funding led by Balnord and Tesi to enhance its high-throughput protein engineering technology.
Amount Raised
$5.7 Million
Round Type
Seed
Investors
Description
Avenue Biosciences has raised $5.7 million in a Seed extension funding round co-led by Balnord and Tesi, with additional contributions from existing investors. This funding is aimed at scaling their high-throughput protein engineering technology. The financing brings the total funding raised by Avenue Biosciences to $8.7 million since 2024. Established to accelerate the discovery of protein biologics, the company develops innovative solutions to overcome production barriers in biotechnology.
Quick answer
Avenue Biosciences raised $5.7 Million in a Seed round, dated January 12, 2026. Investors: Voima Ventures, Inventure, University Of Helsinki, Dimerent, Balnord and Tesi.
- How much did Avenue Biosciences raise?
- Avenue Biosciences raised $5.7 Million in a Seed round on January 12, 2026.
- Who invested in Avenue Biosciences?
- Voima Ventures, Inventure, University Of Helsinki, Dimerent, Balnord and Tesi are named as investors in this round.
- What does Avenue Biosciences do?
- Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers.
- Where is Avenue Biosciences based and how big is it?
- Fundz records about 17 employees.
- Who are the decision-makers at Avenue Biosciences?
- Fundz holds 3 contacts at Avenue Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Avenue Biosciences, and when
A new round usually means Avenue Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avenue Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avenue Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avenue Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avenue Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avenue Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.